Klaria’s subsidiary Cannabis Delivery Sciences (CDS) signs strategic collaboration agreement with Pure Jamaican Limited
Cannabis Delivery Sciences (CDS), a daughter company of Klaria Pharma AB listed on NASDAQ First North (KLAR.ST) today announced that it has entered into an exclusive strategic partnership with Pure Jamaican Limited. Pure Jamaican is a company developing highly modern cultivation of proprietary cannabis strains as well as large-scale pharmaceutical cannabis extraction and Active Pharmaceutical Ingredient (API) production capabilities in Jamaica.The aims for CDS in the collaboration are to conduct R&D, develop products, manufacture and distribute internationally medical grade cannabinoid-